Filing metadata

Accession number
0001628280-22-030745
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Nov 23, 2022
Reporting period
Nov 21, 2022
Description
Insider transaction

Explore SEC Filings Hub